Ncm Capital Management, LLC Moderna, Inc. Transaction History

Ncm Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$118.38 - $210.04 $170,112 - $301,827	1,437 New	1,437 $258,000
Q2 2022 Aug 17, 2022	SELL	$117.13 - $176.59 $156,602 - $236,100	-1,337 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $10,369 - $19,274	-82 Reduced 5.78%	1,337 $230,000
Q4 2021 Feb 15, 2022	BUY	$225.82 - $368.51 $320,438 - $522,915	1,419 New	1,419 $360,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Ncm Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ncm Capital Management, LLC with notifications on news.